{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T23:48:09Z","timestamp":1792280889215,"version":"4.4.0"},"reference-count":33,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,4,7]],"date-time":"2022-04-07T00:00:00Z","timestamp":1649289600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","award":["20TPA35490091"],"award-info":[{"award-number":["20TPA35490091"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:p>Ubiquitin carboxyl-terminal hydrolase L1 (UCHL1) is a deubiquitinase known to play essential roles in the nervous tissue. Myocardial upregulation of UCHL1 was observed in human dilated cardiomyopathy and several animal models of heart disease, but the (patho)physiological significance of UCHL1 in cardiomyocytes remains undefined. Hence, we conducted this study to fill this critical gap. We produced cardiomyocyte-restricted <jats:italic>Uchl1<\/jats:italic> knockout (CKO) by coupling the <jats:italic>Uchl1<\/jats:italic>-floxed allele with transgenic <jats:italic>Myh6-Cre<\/jats:italic> in C57B\/6J inbred mice. Mice transgenic for <jats:italic>Myh6-Cre<\/jats:italic> were used as controls (CTL). Myocardial Uchl1 proteins were markedly reduced in CKO mice but they did not display discernible abnormal phenotype. Ten-week old CTL or CKO mice were subjected to left anterior descending artery ligation (myocardial infarction, MI) or sham surgery (Sham) and characterized at 7- and 28-day after surgery. Compared with Sham mice, significant increases in myocardial UCHL1 proteins were detected in CTL MI but not in CKO MI mice. MI-induced left ventricular (LV) chamber dilation, reduction of ejection fraction (EF) and fractional shortening (FS), and LV anterior wall thinning detected by echocardiography were comparable between the CTL MI and CKO MI groups 7-day post-MI. However, by 28-day post-MI, MI-induced LV chamber dilatation, EF and FS reduction, increases of myocardial ubiquitin conjugates, and increases in the heart weight to body weight ratio and the ventricular weight to body weight ratio were significantly more pronounced in CKO MI than CTL MI mice. As further revealed by LV pressure-volume relationship analyses, CKO MI mice but not CTL MI mice displayed significant decreases in stroke volume, cardiac output, and the maximum rates of LV pressure rising or declining and of LV volume declining, as well as significant increases in LV end-diastolic pressure and Tau, compared with their respective Sham controls. LC3-II flux assays reveal that autophagic flux is decreased in CKO mouse myocardium as well as in cultured Uchl1-deficient cardiomyocytes. In conclusion, UCHL1 of cardiomyocytes is dispensable for development but promotes macroautophagy in cardiomyocytes. Upregulation of UCHL1 in post-MI hearts occurs primarily in the cardiomyocytes and protects against post-MI cardiac remodeling and malfunction likely through supporting autophagic flux and proteostasis during a stress condition.<\/jats:p>","DOI":"10.3389\/fcvm.2022.866901","type":"journal-article","created":{"date-parts":[[2022,4,7]],"date-time":"2022-04-07T04:40:45Z","timestamp":1649306445000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":15,"title":["Ubiquitin Carboxyl-Terminal Hydrolase L1 of Cardiomyocytes Promotes Macroautophagy and Proteostasis and Protects Against Post-myocardial Infarction Cardiac Remodeling and Heart Failure"],"prefix":"10.3389","volume":"9","author":[{"given":"Penglong","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingqi","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingchuan","family":"Geng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faqian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinbao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuejun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,4,7]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.yjmcc.2013.11.006","article-title":"Proteasomal and lysosomal protein degradation and heart disease.","volume":"71","author":"Wang","year":"2014","journal-title":"J Mol Cell Cardiol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.yjmcc.2012.09.012","article-title":"Ubiquitin receptors and protein quality control.","volume":"55","author":"Wang","year":"2013","journal-title":"J Mol Cell Cardiol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"101077","DOI":"10.1016\/j.jbc.2021.101077","article-title":"Deubiquitinating enzymes (DUBs): regulation, homeostasis, and oxidative stress response.","volume":"297","author":"Snyder","year":"2021","journal-title":"J Biol Chem."},{"key":"B4","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1126\/science.2530630","article-title":"The neuron-specific protein PGP 9.5 is a ubiquitin carboxyl-terminal hydrolase.","volume":"246","author":"Wilkinson","year":"1989","journal-title":"Science."},{"key":"B5","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.pneurobio.2009.10.020","article-title":"UCHL1 (PGP 9.5): neuronal biomarker and ubiquitin system protein.","volume":"90","author":"Day","year":"2010","journal-title":"Prog Neurobiol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1002\/cbf.3527","article-title":"Ubiquitin carboxy-terminal hydrolase L1 \u2013 physiology and pathology.","volume":"38","author":"Matuszczak","year":"2020","journal-title":"Cell Biochem Funct."},{"key":"B7","doi-asserted-by":"publisher","first-page":"3489","DOI":"10.1073\/pnas.1222732110","article-title":"Recessive loss of function of the neuronal ubiquitin hydrolase UCHL1 leads to early-onset progressive neurodegeneration.","volume":"110","author":"Bilguvar","year":"2013","journal-title":"Proc Natl Acad Sci USA."},{"key":"B8","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/26652","article-title":"The ubiquitin pathway in Parkinson\u2019s disease.","volume":"395","author":"Leroy","year":"1998","journal-title":"Nature."},{"key":"B9","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/s41416-021-01516-5","article-title":"UCHL1 as a novel target in breast cancer: emerging insights from cell and chemical biology.","volume":"126","author":"Mondal","year":"2022","journal-title":"Br J Cancer."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1158\/1541-7786.MCR-20-0883","article-title":"Deubiquitinase UCHL1 maintains protein homeostasis through the PSMA7-APEH-proteasome axis in high-grade serous ovarian carcinoma.","volume":"19","author":"Tangri","year":"2021","journal-title":"Mol Cancer Res."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1038\/leu.2010.138","article-title":"The de-ubiquitinase UCH-L1 is an oncogene that drives the development of lymphoma in vivo by deregulating PHLPP1 and Akt signaling.","volume":"24","author":"Hussain","year":"2010","journal-title":"Leukemia."},{"key":"B12","doi-asserted-by":"publisher","first-page":"12020","DOI":"10.1021\/jacs.0c04527","article-title":"Discovery of a potent and selective covalent inhibitor and activity-based probe for the deubiquitylating enzyme UCHL1, with antifibrotic activity.","volume":"142","author":"Panyain","year":"2020","journal-title":"J Am Chem Soc."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1016\/j.jhep.2015.07.034","article-title":"Ubiquitin C-terminal hydrolase 1: a novel functional marker for liver myofibroblasts and a therapeutic target in chronic liver disease.","volume":"63","author":"Wilson","year":"2015","journal-title":"J Hepatol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"174045","DOI":"10.1016\/j.ejphar.2021.174045","article-title":"UCHL1 inhibition attenuates cardiac fibrosis via modulation of nuclear factor-kappaB signaling in fibroblasts.","volume":"900","author":"Gong","year":"2021","journal-title":"Eur J Pharmacol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"10604","DOI":"10.1038\/s41598-020-67746-4","article-title":"Ubiquitin C-terminal hydrolase L1 (UCHL1) regulates post-myocardial infarction cardiac fibrosis through glucose-regulated protein of 78 kDa (GRP78).","volume":"10","author":"Lei","year":"2020","journal-title":"Sci Rep."},{"key":"B16","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1002\/pmic.200390029","article-title":"Hyperubiquitination of proteins in dilated cardiomyopathy.","volume":"3","author":"Weekes","year":"2003","journal-title":"Proteomics."},{"key":"B17","doi-asserted-by":"publisher","first-page":"H1817","DOI":"10.1152\/ajpheart.00445.2013","article-title":"Cardiac sympathetic innervation and PGP9.5 expression by cardiomyocytes after myocardial infarction: effects of central MR blockade.","volume":"305","author":"Drobysheva","year":"2013","journal-title":"Am J Physiol Heart Circ Physiol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"H551","DOI":"10.1152\/ajpheart.00771.2012","article-title":"Altered ubiquitin-proteasome signaling in right ventricular hypertrophy and failure.","volume":"305","author":"Rajagopalan","year":"2013","journal-title":"Am J Physiol Heart Circ Physiol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"e94658","DOI":"10.1371\/journal.pone.0094658","article-title":"Ubiquitin carboxyl terminal hydrolyase L1-suppressed autophagic degradation of p21WAF1\/Cip1 as a novel feedback mechanism in the control of cardiac fibroblast proliferation.","volume":"9","author":"Zhang","year":"2014","journal-title":"PLoS One."},{"key":"B20","doi-asserted-by":"publisher","first-page":"eaax4826","DOI":"10.1126\/sciadv.aax4826","article-title":"The deubiquitinase UCHL1 regulates cardiac hypertrophy by stabilizing epidermal growth factor receptor.","volume":"6","author":"Bi","year":"2020","journal-title":"Sci Adv."},{"key":"B21","doi-asserted-by":"publisher","first-page":"H401","DOI":"10.1152\/ajpheart.00292.2008","article-title":"Proteasome inhibition attenuates coxsackievirus-induced myocardial damage in mice.","volume":"295","author":"Gao","year":"2008","journal-title":"Am J Physiol Heart Circ Physiol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1038\/s41440-020-0486-1","article-title":"Blockage of UCHL1 activity attenuates cardiac remodeling in spontaneously hypertensive rats.","volume":"43","author":"Han","year":"2020","journal-title":"Hypertens Res."},{"key":"B23","doi-asserted-by":"publisher","first-page":"116699","DOI":"10.1016\/j.lfs.2019.116699","article-title":"UCHL1 regulates muscle fibers and mTORC1 activity in skeletal muscle.","volume":"233","author":"Gao","year":"2019","journal-title":"Life Sci."},{"key":"B24","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1172\/JCI119509","article-title":"Gene recombination in postmitotic cells. Targeted expression of Cre recombinase provokes cardiac-restricted, site-specific rearrangement in adult ventricular muscle in vivo.","volume":"100","author":"Agah","year":"1997","journal-title":"J Clin Invest."},{"key":"B25","doi-asserted-by":"publisher","first-page":"e004044","DOI":"10.1161\/CIRCHEARTFAILURE.117.004044","article-title":"Myocardial upregulation of cathepsin D by ischemic heart disease promotes autophagic flux and protects against cardiac remodeling and heart failure.","volume":"10","author":"Wu","year":"2017","journal-title":"Circ Heart Fail."},{"key":"B26","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1161\/CIRCRESAHA.119.316007","article-title":"The calcineurin-TFEB-p62 pathway mediates the activation of cardiac macroautophagy by proteasomal malfunction.","volume":"127","author":"Pan","year":"2020","journal-title":"Circ Res."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1161\/CIRCRESAHA.108.180117","article-title":"Alpha B-crystallin suppresses pressure overload cardiac hypertrophy.","volume":"103","author":"Kumarapeli","year":"2008","journal-title":"Circ Res."},{"key":"B28","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.yjmcc.2017.10.003","article-title":"TFEB activation protects against cardiac proteotoxicity via increasing autophagic flux.","volume":"113","author":"Pan","year":"2017","journal-title":"J Mol Cell Cardiol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.ab.2013.05.027","article-title":"Stain-Free total protein staining is a superior loading control to beta-actin for Western blots.","volume":"440","author":"Gilda","year":"2013","journal-title":"Anal Biochem."},{"key":"B30","doi-asserted-by":"publisher","first-page":"R110003871","DOI":"10.1074\/mcp.R110.003871","article-title":"Trimming of ubiquitin chains by proteasome-associated deubiquitinating enzymes.","volume":"10","author":"Lee","year":"2011","journal-title":"Mol Cell Proteomics."},{"key":"B31","doi-asserted-by":"publisher","first-page":"H304","DOI":"10.1152\/ajpheart.00145.2017","article-title":"Autophagy modulation: a potential therapeutic approach in cardiac hypertrophy.","volume":"313","author":"Wang","year":"2017","journal-title":"Am J Physiol Heart Circ Physiol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1161\/CIRCRESAHA.110.230607","article-title":"Perturbation of cullin deneddylation via conditional Csn8 ablation impairs the ubiquitin-proteasome system and causes cardiomyocyte necrosis and dilated cardiomyopathy in mice.","volume":"108","author":"Su","year":"2011","journal-title":"Circ Res."},{"key":"B33","doi-asserted-by":"publisher","first-page":"102295","DOI":"10.1016\/j.redox.2022.102295","article-title":"UCHL1 protects against ischemic heart injury via activating HIF-1\u03b1 signal pathway.","volume":"52","author":"Geng","year":"2022","journal-title":"Redox Biol."}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2022.866901\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,7]],"date-time":"2022-04-07T04:40:49Z","timestamp":1649306449000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2022.866901\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,7]]},"references-count":33,"alternative-id":["10.3389\/fcvm.2022.866901"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2022.866901","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,7]]},"article-number":"866901"}}